These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8904547)

  • 41. Meta-analysis of the Risk of Torsades de Pointes in patients treated with intravenous racemic sotalol.
    Marill KA; Runge T
    Acad Emerg Med; 2001 Feb; 8(2):117-24. PubMed ID: 11157286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does Sotalol Still Have a Role in the Management of Arrhythmias?
    Semasinghe Bandaralage SP; Nirthanan S; Niranjan S
    Am J Ther; 2019; 26(1):e161-e169. PubMed ID: 27759583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY.
    Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D
    Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seventy-four defibrillations for sotalol-induced torsades de pointes.
    Sürücü H; Tatli E; Değirmenci A; Gökmen G
    Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
    Hii JT; Wyse DG; Gillis AM; Cohen JM; Mitchell LB
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1568-70. PubMed ID: 1721143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
    Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
    Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy.
    Singh SN; Lazin A; Cohen A; Johnson M; Fletcher RD
    Am Heart J; 1991 Feb; 121(2 Pt 1):601-2. PubMed ID: 1990770
    [No Abstract]   [Full Text] [Related]  

  • 50. Torsades de pointes with terfenadine ingestion.
    June RA; Nasr I
    Am J Emerg Med; 1997 Sep; 15(5):542-3. PubMed ID: 9270401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
    Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
    Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemiparesis and torsade de pointes under low-dose sotalol therapy].
    Sieber C; Weiss P; Follath F
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
    Pohjola-Sintonen S
    Duodecim; 1993; 109(2):164-6. PubMed ID: 8013320
    [No Abstract]   [Full Text] [Related]  

  • 55. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 56. Torsades de pointes complicating treatment with terodiline.
    McLeod AA; Thorogood S; Barnett S
    BMJ; 1991 Jun; 302(6790):1469. PubMed ID: 1676922
    [No Abstract]   [Full Text] [Related]  

  • 57. Torsades de pointes ventricular tachycardia associated with terfenadine and paracetamol self medication.
    Matsis PP; Easthope RN
    N Z Med J; 1994 Oct; 107(987):402-3. PubMed ID: 7936480
    [No Abstract]   [Full Text] [Related]  

  • 58. Torsades de pointes occurring in association with terfenadine use.
    Mathews DR; McNutt B; Okerholm R; Flicker M; McBride G
    JAMA; 1991 Nov; 266(17):2375-6. PubMed ID: 1920744
    [No Abstract]   [Full Text] [Related]  

  • 59. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
    Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
    Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
    [No Abstract]   [Full Text] [Related]  

  • 60. Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
    Pratt CM; Camm AJ; Cooper W; Friedman PL; MacNeil DJ; Moulton KM; Pitt B; Schwartz PJ; Veltri EP; Waldo AL
    Am J Cardiol; 1998 Apr; 81(7):869-76. PubMed ID: 9555777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.